MICHELLE HILLIARD: Open Payments
NPI 1003249384 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$289 in 14 payments from 8 companies in 2025. Trend: 2023 $254 · 2024 $210 · 2025 $289
Food & beverage: $289
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 3 | $62 |
| Ardelyx, Inc. | 2 | $56 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $52 |
| AstraZeneca Pharmaceuticals LP | 2 | $36 |
| Exact Sciences Corporation | 2 | $33 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| ABBVIE INC. | 1 | $15 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
Products named: IBSRELA, CAPLYTA, FARXIGA, The Cologuard Plus Collection Kit, MOUNJARO, ZEPBOUND, REXULTI, QULIPTA.
Industry payments across LA — which companies pay providers there.
